Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InflaRx (IFRX) EPS (Weighted Average and Diluted) (2016 - 2026)

InflaRx's EPS (Weighted Average and Diluted) history spans 9 years, with the latest figure at -$0.08 for Q1 2026.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 41.09% to -$0.08 in Q1 2026 year-over-year; TTM through Mar 2026 was -$0.08, a 41.09% increase, with the full-year FY2025 number at -$0.79, up 5.03% from a year prior.
  • EPS (Weighted Average and Diluted) hit -$0.08 in Q1 2026 for InflaRx, down from $0.53 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for IFRX hit a ceiling of $0.74 in Q4 2024 and a floor of -$247563.4 in Q1 2023.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$31411.0 across 5 years, with a median of -$0.17 in 2025.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): tumbled 73911740.36% in 2023 and later soared 433.07% in 2024.
  • Tracing IFRX's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.17 in 2022, then plummeted by 33.69% to -$0.22 in 2023, then surged by 433.07% to $0.74 in 2024, then decreased by 28.7% to $0.53 in 2025, then tumbled by 114.57% to -$0.08 in 2026.
  • Business Quant data shows EPS (Weighted Average and Diluted) for IFRX at -$0.08 in Q1 2026, $0.53 in Q4 2025, and -$0.18 in Q3 2025.